Literature DB >> 11013123

The stress-responsive MAP kinase p38 is activated by low-flow ischemia in the in situ porcine heart.

H Lüss1, J Neumann, W Schmitz, R Schulz, G Heusch.   

Abstract

Stress-responsive p38 MAP kinase is activated by phosphorylation during global and severe regional myocardial ischemia. However, it is unknown whether or not moderate, low-flow ischemia also activates p38 MAP kinase. Therefore, we investigated p38 MAP kinase activation in an established model of short-term hibernation and stunning. In anesthetized swine, coronary blood flow into the left anterior descending coronary artery was decreased in order to reduce regional contractile function by identical with 50%. Transmural myocardial biopsies were taken before (controls) and during ischemia as well as after reperfusion. Creatine phosphate content, after an early ischemic reduction, recovered to control values at 90 min ischemia. The expression of phospholamban, SERCA2a, calsequestrin, and troponin inhibitor was unchanged under these conditions (Northern and Western blotting). At 8 min of ischemia, however, p38 MAP kinase was activated to 221% of the pre-ischemic value as judged by its elevated phosphorylation state. Then, it returned to control values by 85 min ischemia. We conclude that low-flow ischemia transiently activates the stress-responsive p38 MAP kinase which might act to trigger cardioprotective events. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013123     DOI: 10.1006/jmcc.2000.1213

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

1.  Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.

Authors:  Jason N Peart; Eric R Gross; John P Headrick; Garretta J Gross
Journal:  J Mol Cell Cardiol       Date:  2007-02-28       Impact factor: 5.000

Review 2.  Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury.

Authors:  Dong Liu; Liqun Xu; Xiaoyan Zhang; Changhong Shi; Shubin Qiao; Zhiqiang Ma; Jiansong Yuan
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.